131 results
Page 2 of 7
8-K
EX-10.1
uxv 9w88vjapo2z
2 Aug 22
Entry into a Material Definitive Agreement
4:38pm
8-K
EX-10.1
7l47u9h196t34a
27 Jul 22
Entry into a Material Definitive Agreement
7:08am
8-K
87jyjax0
2 Jun 22
Submission of Matters to a Vote of Security Holders
4:30pm
DEFA14A
en9k89qcq qa
20 Apr 22
Additional proxy soliciting materials
4:09pm
8-K
EX-1.1
6kzbnjff
24 Mar 22
Apellis Pharmaceuticals Announces Pricing of Public Offering of Common Stock
8:18pm
424B5
hhyem39f4z 99f
24 Mar 22
Prospectus supplement for primary offering
8:02pm
424B5
4patx28vbw64q 8s
23 Mar 22
Prospectus supplement for primary offering
5:14pm
S-8
cd75ioqf1ixii5k9x2v
28 Feb 22
Registration of securities for employees
5:06pm
S-8
EX-23.2
0sphk nsaq
28 Feb 22
Registration of securities for employees
5:06pm
8-K
EX-1.1
wmqjq
20 Jan 22
Entry into a Material Definitive Agreement
4:55pm
424B5
1ecrq0
20 Jan 22
Prospectus supplement for primary offering
4:45pm
8-K
fjodnudpone nu
10 Jan 22
Results of Operations and Financial Condition
8:00am
8-K
EX-1.1
iobxh8bezae6k0830wz
17 Nov 21
Apellis Pharmaceuticals Announces Pricing of Public Offering of Common Stock
9:04am
424B5
u7uys06m0iwq320
17 Nov 21
Prospectus supplement for primary offering
9:02am
424B5
6lana0v5se7s
15 Nov 21
Prospectus supplement for primary offering
5:24pm